Bachem (OTCMKTS:BCHMF) vs. ARQ (NASDAQ:ARQ) Critical Comparison

Bachem (OTCMKTS:BCHMF) and ARQ (NASDAQ:ARQ) are both materials companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, profitability, earnings, analyst recommendations, institutional ownership, risk and valuation.

Analyst Ratings

This is a summary of recent recommendations for Bachem and ARQ, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Bachem	1	0	3	0	2.50
ARQ	1	1	1	0	2.00

ARQ has a consensus target price of $5.00, suggesting a potential upside of 120.26%. Given ARQ’s higher possible upside, analysts plainly believe ARQ is more favorable than Bachem.

Earnings & Valuation

This table compares Bachem and ARQ”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Bachem	N/A	N/A	N/A	N/A	N/A
ARQ	$120.34 million	0.81	-$52.61 million	($1.29)	-1.76

Bachem has higher earnings, but lower revenue than ARQ.

Insider and Institutional Ownership

18.5% of ARQ shares are held by institutional investors. 20.1% of ARQ shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Profitability

This table compares Bachem and ARQ’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Bachem	N/A	N/A	N/A
ARQ	-42.33%	-2.48%	-1.85%

Summary

Bachem beats ARQ on 5 of the 9 factors compared between the two stocks.

About Bachem

Bachem Holding AG, together with its subsidiaries, provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide. The company engages in the development, production, and regulatory support of peptide active pharmaceutical ingredients, such as peptide and oligonucleotide new chemical entities (NCEs). It also offers commercial NCEs and generics; and project management, quality and regulatory, analytical, good manufacturing practice production, research grade production, and supply and vertical integration services. Bachem Holding AG was founded in 1971 and is headquartered in Bubendorf, Switzerland.

About ARQ

Arq, Inc. is a holding company. It engages in the provision of environmental and emission control equipment to the power generation industry. The company operates through the following Segments: Refined Coal and Advanced Purification Technologies. The Refined Coal segment includes the Tinuum Group, Tinuum Services, and GWN Manager. The Advanced Purification Technologies segment refers to the sale of Activated Carbon Injection and Dry Sorbent Injection equipment systems, chemical sales, consulting services, and other sales related to the reduction of emissions in the coal-fired electric generation process and the electric utility industry. The company was founded in 1996 and is headquartered in Greenwood Village, CO.